The maximum value allocated to the Program is RON 88.5m.

MedLife announced to its shareholders that the Board of Directors of the Company adopted on 30 June the share buy-back program of the Company that will be initiate as of 7 July 2020.

The approved buy-back of a maximum number of 1.77m own shares will last for a maximum period of 18 months from the date of publication of the decision and shall not exceed the 10% threshold of the share capital of the Company.

The purchase price of shares under the Program will be between RON 10 and RON 50, subject to the applicable legal provisions and restrictions. Note that the maximum value allocated to the Program is RON 88.5m (calculated as the maximum number of 1,770,000 own shares at a price per share of RON 50).

The own shares acquired under the Program will be offered to former or current members of management or former or current employees of some of the subsidiaries of the Company in exchange for the shares held by them in the respective subsidiaries of the Company.